Abstract Intestinal microbiota metabolism of choline and phosphatidylcholine produces trimethylamine (TMA), which is further metabolized to a proatherogenic species, trimethylamine- N -oxide (TMAO)
According to a 2024 report by Harvard Health, the Food and Drug Administration has approved a total of 10 GLP-1 medications for treating diabetes and obesity, with other applications like drug addiction still being studied
Persistently supraphysiologic IGF-1 is associated with insulin resistance, edema and a theoretical tumor-growth concern
In clinical settings, IV administration allows glutathione to bypass digestion and enter circulation directly, offering more predictable absorption. According to Patel, IVs can be effective in the short-term, but can create sharp spikes in blood levels that rise quickly and fade just as fast. After years of research, Patel developed a patented sub-nano topical delivery system designed to transport reduced glutathione across the skin barrier and into circulation, which can be found in his Auro Wellness products